Phase 2 Randomized Clinical Study of Netarsudil Ophthalmic Solution in Japanese Patients with Primary Open-Angle Glaucoma or Ocular Hypertension

被引：0
|
作者：
Makoto Araie
Kazuhisa Sugiyama
Kenji Aso
Koji Kanemoto
Kalyani Kothapalli
Casey Kopczynski
Michelle Senchyna
David A. Hollander
机构：
[1] Kanto Central Hospital of the Mutual Aid Association of Public School Teachers,Department of Ophthalmology
[2] Kanazawa University Graduate School of Medical Science,undefined
[3] Aerie Pharmaceuticals Ireland Ltd. (Japan Branch),undefined
[4] Statistics and Data Corporation,undefined
[5] Aerie Pharmaceuticals,undefined
[6] Inc.,undefined
来源：
Advances in Therapy | 2021年 / 38卷
关键词：
Conjunctival hyperemia; Glaucoma; Intraocular pressure; Netarsudil; Rho-associated protein kinase;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1757 / 1775
页数：18
相关论文
共 50 条
  • [1] Phase 2 Randomized Clinical Study of Netarsudil Ophthalmic Solution in Japanese Patients with Primary Open-Angle Glaucoma or Ocular Hypertension
    Araie, Makoto
    Sugiyama, Kazuhisa
    Aso, Kenji
    Kanemoto, Koji
    Kothapalli, Kalyani
    Kopczynski, Casey
    Senchyna, Michelle
    Hollander, David A.
    ADVANCES IN THERAPY, 2021, 38 (04) : 1757 - 1775
  • [2] Netarsudil ophthalmic solution 0.02% for the treatment of patients with open-angle glaucoma or ocular hypertension
    Kopczynski, C. C.
    Heah, T.
    DRUGS OF TODAY, 2018, 54 (08) : 467 - 478
  • [3] Efficacy and safety of netarsudil 0.02% ophthalmic solution in patients with open-angle glaucoma and ocular hypertension
    Berryman, Jefferson D.
    Novack, Gary D.
    EXPERT REVIEW OF OPHTHALMOLOGY, 2019, 14 (4-5) : 191 - 197
  • [4] Pooled Efficacy and Safety Profile of Netarsudil Ophthalmic Solution 0.02% in Patients With Open-angle Glaucoma or Ocular Hypertension
    Singh, Inder P.
    Fechtner, Robert D.
    Myers, Jonathan S.
    Kim, Terry
    Usner, Dale W.
    McKee, Hayley
    Sheng, Huan
    Lewis, Richard A.
    Heah, Theresa
    Kopczynski, Casey C.
    JOURNAL OF GLAUCOMA, 2020, 29 (10) : 878 - 884
  • [5] Netarsudil and latanoprost ophthalmic solution for the reduction of intraocular pressure in open-angle glaucoma or ocular hypertension
    Aref, Ahmad A.
    Geyman, Lawrence S.
    Zakieh, Abdel-Rahman
    Alotaibi, Humoud M.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2019, 12 (12) : 1073 - 1079
  • [6] A Randomized, Phase 2 Study of 24-h Efficacy and Tolerability of Netarsudil in Ocular Hypertension and Open-Angle Glaucoma
    James H. Peace
    Hayley J. McKee
    Casey C. Kopczynski
    Ophthalmology and Therapy, 2021, 10 : 89 - 100
  • [7] A Randomized, Phase 2 Study of 24-h Efficacy and Tolerability of Netarsudil in Ocular Hypertension and Open-Angle Glaucoma
    Peace, James H.
    McKee, Hayley J.
    Kopczynski, Casey C.
    OPHTHALMOLOGY AND THERAPY, 2021, 10 (01) : 89 - 100
  • [8] Netarsudil for the Treatment of Open-Angle Glaucoma and Ocular Hypertension: A Literature Review
    Gonzalez, Lipton E.
    Boylan, Paul M.
    ANNALS OF PHARMACOTHERAPY, 2021, 55 (08) : 1025 - 1036
  • [9] Omidenepag isopropyl ophthalmic solution for open-angle glaucoma and ocular hypertension: an update
    Aihara, Makoto
    Aung, Tin
    Bacharach, Jason
    Cantor, Louis
    Kook, Michael
    Nakazawa, Toru
    Park, Ki Ho
    Lu, Da-Wen
    EXPERT REVIEW OF OPHTHALMOLOGY, 2021, 16 (04) : 243 - 250
  • [10] Netarsudil Improves Trabecular Outflow Facility in Patients with Primary Open Angle Glaucoma or Ocular Hypertension: A Phase 2 Study
    Sit, Arthur J.
    Gupta, Divakar
    Kazemi, Arash
    McKee, Hayley
    Challa, Pratap
    Liu, Katy C.
    Lopez, Jae
    Kopczynski, Casey
    Heah, Theresa
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2021, 226 : 262 - 269
12345